journal
https://read.qxmd.com/read/38631995/re-first-in-human-safety-imaging-and-dosimetry-of-a-carbonic-anhydrase-ix-targeting-peptide-68-ga-ga-dpi-4452-in-patients-with-clear-cell-renal-cell-carcinoma
#1
JOURNAL ARTICLE
Alice Thomson, Carlotta Castillo, Henrike Graefen, Sachin Perera, Nathan Lawrentschuk, Marlon Perera, Renu Eapen, Declan G Murphy
No abstract text is available yet for this article.
April 16, 2024: European Urology
https://read.qxmd.com/read/38631994/re-stereotactic-ablative-body-radiotherapy-for-primary-kidney-cancer-trog-15-03-fastrack-ii-a-non-randomised-phase-2-trial
#2
JOURNAL ARTICLE
Aimin Jiang, Ying Liu, Chen Cai, Peng Luo, Linhui Wang
No abstract text is available yet for this article.
April 16, 2024: European Urology
https://read.qxmd.com/read/38631993/re-enfortumab-vedotin-and-pembrolizumab-in-untreated-advanced-urothelial-cancer
#3
JOURNAL ARTICLE
David C Chen, Haidar AlSaffar, Henrike Graefen, Sachin Perera, Elio Mazzone, Marlon L Perera, Nathan Lawrentschuk, Declan G Murphy
No abstract text is available yet for this article.
April 16, 2024: European Urology
https://read.qxmd.com/read/38627151/orthotopic-robot-assisted-kidney-transplantation-surgical-technique-and-preliminary-results
#4
JOURNAL ARTICLE
Francesc Vigués, Begoña Etcheverry, José I Perez Reggeti, Josep Maria Gaya, Angelo Territo, Andrea Gallioli, Camille Berquin, Giuseppe Basile, José F Suárez, Maria Fiol, Oscar Buisan, Lluís Riera, Thomas Prudhomme, Nicolas Doumerc, Alessio Pecoraro, Alberto Breda
BACKGROUND AND OBJECTIVE: Orthotopic kidney transplantation (KT) has been proposed as an option for patients ineligible for heterotopic KT. In this scenario, orthotopic robot-assisted KT (oRAKT) represents a novel, minimally invasive alternative to the open approach. Here we describe the largest oRAKT series of patients, with a focus on the surgical technique, perioperative surgical outcomes, and functional results. METHODS: We queried prospectively maintained databases from three referral centers to identify patients who underwent oRAKT and evaluated surgical and functional outcomes...
April 15, 2024: European Urology
https://read.qxmd.com/read/38627150/european-association-of-urology-european-society-for-paediatric-urology-guidelines-on-paediatric-urology-summary-of-the-2024-updates
#5
REVIEW
Michele Gnech, Allon van Uitert, Uchenna Kennedy, Martin Skott, Alexandra Zachou, Berk Burgu, Marco Castagnetti, Lisette't Hoen, Fardod O'Kelly, Josine Quaedackers, Yazan F Rawashdeh, Mesrur Selcuk Silay, Guy Bogaert, Christian Radmayr
BACKGROUND AND OBJECTIVE: We present an overview of the 2024 updates for the European Association of Urology (EAU)/European Society for Paediatric Urology (ESPU) guidelines on paediatric urology to offer evidence-based standards for perioperative management, minimally invasive surgery (MIS), hydrocele, congenital lower urinary tract obstruction (CLUTO), trauma/emergencies, and fertility preservation. METHODS: A broad literature search was performed for each condition...
April 15, 2024: European Urology
https://read.qxmd.com/read/38614823/re-fgfr-inhibition-augments-anti-pd-1-efficacy-in-murine-fgfr3-mutant-bladder-cancer-by-abrogating-immunosuppression
#6
JOURNAL ARTICLE
Marie-Pier St-Laurent, Peter C Black
No abstract text is available yet for this article.
April 12, 2024: European Urology
https://read.qxmd.com/read/38614822/re-multi-omic-profiling-of-clear-cell-renal-cell-carcinoma-identifies-metabolic-reprogramming-associated-with-disease-progression
#7
JOURNAL ARTICLE
Aimin Jiang, Le Qu, Chen Cai, Peng Luo, Linhui Wang
No abstract text is available yet for this article.
April 12, 2024: European Urology
https://read.qxmd.com/read/38614821/re-michele-gnech-lisette-t-hoen-alexandra-zachou-et-al-update-and-summary-of-the-european-association-of-urology-european-society-of-paediatric-urology-paediatric-guidelines-on-vesicoureteral-reflux-in-children-eur-urol-in-press-https-doi-org-10-1016-j-eururo
#8
LETTER
https://read.qxmd.com/read/38614820/eau-eanm-estro-esur-isup-siog-guidelines-on-prostate-cancer-2024-update-part-i-screening-diagnosis-and-local-treatment-with-curative-intent
#9
REVIEW
Philip Cornford, Roderick C N van den Bergh, Erik Briers, Thomas Van den Broeck, Oliver Brunckhorst, Julie Darraugh, Daniel Eberli, Gert De Meerleer, Maria De Santis, Andrea Farolfi, Giorgio Gandaglia, Silke Gillessen, Nikolaos Grivas, Ann M Henry, Michael Lardas, Geert J L H van Leenders, Matthew Liew, Estefania Linares Espinos, Jan Oldenburg, Inge M van Oort, Daniela E Oprea-Lager, Guillaume Ploussard, Matthew J Roberts, Olivier Rouvière, Ivo G Schoots, Natasha Schouten, Emma J Smith, Johan Stranne, Thomas Wiegel, Peter-Paul M Willemse, Derya Tilki
BACKGROUND AND OBJECTIVE: The European Association of Urology (EAU)-European Association of Nuclear Medicine (EANM)-European Society for Radiotherapy and Oncology (ESTRO)-European Society of Urogenital Radiology (ESUR)-International Society of Urological Pathology (ISUP)-International Society of Geriatric Oncology (SIOG) guidelines provide recommendations for the management of clinically localised prostate cancer (PCa). This paper aims to present a summary of the 2024 version of the EAU-EANM-ESTRO-ESUR-ISUP-SIOG guidelines on the screening, diagnosis, and treatment of clinically localised PCa...
April 12, 2024: European Urology
https://read.qxmd.com/read/38609797/re-targeted-inhibition-of-cyp11a1-in-castration-resistant-prostate-cancer
#10
JOURNAL ARTICLE
Markus Grabbert, Nikolaos Liakos, Christian Gratzke
No abstract text is available yet for this article.
April 11, 2024: European Urology
https://read.qxmd.com/read/38604930/re-kosuke-takemura-audreylie-lemelin-matthew-s-ernst-et-al-outcomes-of-patients-with-brain-metastases-from-renal-cell-carcinoma-receiving-first-line-therapies-results-from-the-international-metastatic-renal-cell-carcinoma-database-consortium-eur-urol-in-press
#11
LETTER
https://read.qxmd.com/read/38599993/re-erdafitinib-in-bcg-treated-high-risk-non-muscle-invasive-bladder-cancer
#12
JOURNAL ARTICLE
Marko Babjuk
No abstract text is available yet for this article.
April 9, 2024: European Urology
https://read.qxmd.com/read/38599992/re-assessment-of-artificial-intelligence-chatbot-responses-to-top-searched-queries-about-cancer
#13
JOURNAL ARTICLE
Francesco Cei, Giovanni Enrico Cacciamani
No abstract text is available yet for this article.
April 9, 2024: European Urology
https://read.qxmd.com/read/38599991/reply-to-giancarlo-marra-marco-oderda-paolo-gontero-and-lorenzo-richiardi-s-letter-to-the-editor-re-jim-c-hu-melissa-assel-mohamad-e-allaf-et-al-transrectal-magnetic-resonance-imaging-targeted-and-systematic-prostate-biopsy-to-prevent-infectious-complications
#14
LETTER
https://read.qxmd.com/read/38599990/re-enfortumab-vedotin-and-pembrolizumab-in-untreated-advanced-urothelial-cancer
#15
JOURNAL ARTICLE
Niklas Klümper, Francisco E Vera-Badillo, Markus Eckstein, Boris Hadaschik, Viktor Grünwald
No abstract text is available yet for this article.
April 9, 2024: European Urology
https://read.qxmd.com/read/38594103/summary-of-the-2024-update-of-the-european-association-of-urology-guidelines-on-neurourology
#16
REVIEW
Andrea M Sartori, Thomas M Kessler, David M Castro-Díaz, Peter de Keijzer, Giulio Del Popolo, Hazel Ecclestone, Dennis Frings, Jan Groen, Rizwan Hamid, Gilles Karsenty, Stefania Musco, Bárbara Padilla-Fernández, Jürgen Pannek, Natasha Schouten, Angela van der Vorm, Bertil F M Blok
BACKGROUND AND OBJECTIVE: Most patients with neurourological disorders require lifelong medical care. The European Association of Urology (EAU) regularly updates guidelines for diagnosis and treatment of these patients. The objective of this review is to provide a summary of the 2024 updated EAU guidelines on neurourology. METHODS: A structured literature review covering the timeframe 2021-2023 was conducted for the guideline update. A level of evidence and a strength rating were assigned for each recommendation on the basis of the literature data...
April 8, 2024: European Urology
https://read.qxmd.com/read/38584074/re-bertrand-tombal-sean-collins-alicia-k-morgans-et-al-impact-of-relugolix-versus-leuprolide-on-the-quality-of-life-of-men-with-advanced-prostate-cancer-results-from-the-phase-3-hero-study-eur-urol-2023-84-579-87
#17
LETTER
https://read.qxmd.com/read/38582713/characterization-of-responses-to-lenvatinib-plus-pembrolizumab-in-patients-with-advanced-renal-cell-carcinoma-at-the-final-prespecified-survival-analysis-of-the-phase-3-clear-study
#18
JOURNAL ARTICLE
Robert J Motzer, Toni K Choueiri, Thomas Hutson, Sun Young Rha, Javier Puente, Aly-Khan A Lalani, Eric Winquist, Masatoshi Eto, Naveen S Basappa, Nizar M Tannir, Ulka Vaishampayan, Georg A Bjarnason, Stéphane Oudard, Viktor Grünwald, Joseph Burgents, Ran Xie, Jodi McKenzie, Thomas Powles
In the phase 3 CLEAR trial, lenvatinib plus pembrolizumab (L + P) showed superior efficacy versus sunitinib in treatment-naïve patients with advanced renal cell carcinoma (aRCC). The combination treatment was associated with a robust objective response rate of 71%. Here we report tumor responses for patients in the L + P arm in CLEAR, with median follow-up of ∼4 yr at the final prespecified overall survival (OS) analysis. Tumor responses were assessed by independent review using Response Evaluation Criteria in Solid Tumors v1...
April 5, 2024: European Urology
https://read.qxmd.com/read/38580518/infigratinib-versus-placebo-for-patients-with-high-risk-resected-urothelial-cancer-bearing-an-fgfr3-genomic-alteration-results-from-the-proof302-phase-3-trial
#19
LETTER
Sumanta K Pal, Petros Grivas, Shilpa Gupta, Nazli Dizman, Zeynep Zengin, Begona P Valderrama, Alejo Rodriguez-Vida, Florian Roghmann, Elena Sevillano Fernandez, Surena F Matin, Yohann Loriot, Srikala S Sridhar, Guru Sonpavde, Mark T Fleming, Seth P Lerner, Joaquim Bellmunt, Viraj Master, Abhishek Tripathi, Kim Davis, David van Veenhuyzen, Richard Weng, Siamak Daneshmand
No abstract text is available yet for this article.
April 4, 2024: European Urology
https://read.qxmd.com/read/38570248/re-marc-oliver-grimm-mototsuga-oya-toni-k-choueiri-et-al-impact-of-prior-cytoreductive-nephrectomy-on-efficacy-in-patients-with-synchronous-metastatic-renal-cell-carcinoma-treated-with-avelumab-plus-axitinib-or-sunitinib-post-hoc-analysis-from-the-javelin-renal
#20
LETTER
journal
journal
20110
1
2
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.